Cargando…

A Novel Aurora-A Inhibitor, BPR1K0609S1, Sensitizes Colorectal Tumor cells to 5-Fluorofracil (5-FU) Treatment

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Shionome, Yoshimi, Lin, Wen-Hsing, Shiao, Hui-Yi, Hsieh, Hsing-Pang, Hsu, John Tsu-An, Ouchi, Toru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2013
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3805899/ http://dx.doi.org/10.7150/ijbs.9.947

Ejemplares similares

A Novel Aurora-A Inhibitor, BPR1K0609S1, Sensitizes Colorectal Tumor cells to 5-Fluorofracil (5-FU) Treatment
por: Shionome, Yoshimi, et al.
Publicado: (2013)

BPR1K653, a Novel Aurora Kinase Inhibitor, Exhibits Potent Anti-Proliferative Activity in MDR1 (P-gp170)-Mediated Multidrug-Resistant Cancer Cells
por: Cheung, Chun Hei Antonio, et al.
Publicado: (2011)

Integrity of p53 Associated Pathways Determines Induction of Apoptosis of Tumor Cells Resistant to Aurora-A Kinase Inhibitors
por: Shionome, Yoshimi, et al.
Publicado: (2013)

Pyrazole compound BPR1P0034 with potent and selective anti-influenza virus activity
por: Shih, Shin-Ru, et al.
Publicado: (2010)

Tubulin-Destabilizing Agent BPR0L075 Induces Vascular-Disruption in Human Breast Cancer Mammary Fat Pad Xenografts
por: Liu, Li, et al.
Publicado: (2012)

An Antimitotic and Antivascular Agent BPR0L075 Overcomes Multidrug Resistance and Induces Mitotic Catastrophe in Paclitaxel-Resistant Ovarian Cancer Cells
por: Wang, Xiaolei, et al.
Publicado: (2013)

MicroRNA-587 antagonizes 5-FU-induced apoptosis and confers drug resistance by regulating PPP2R1B expression in colorectal cancer
por: Zhang, Y, et al.
Publicado: (2016)

Securin Enhances the Anti-Cancer Effects of 6-Methoxy-3-(3′,4′,5′-Trimethoxy-Benzoyl)-1H-Indole (BPR0L075) in Human Colorectal Cancer Cells
por: Tseng, Ho-Hsing, et al.
Publicado: (2012)

BPR1J373, a novel multitargeted kinase inhibitor, effectively suppresses the growth of gastrointestinal stromal tumor
por: Tsai, Hui‐Jen, et al.
Publicado: (2018)

Physiological and Oncogenic Aurora-A Pathway
por: SAEKI, Toshiaki, et al.
Publicado: (2009)

Evaluation of the Antitumor Effects of BPR1J-340, a Potent and Selective FLT3 Inhibitor, Alone or in Combination with an HDAC Inhibitor, Vorinostat, in AML Cancer
por: Lin, Wen-Hsing, et al.
Publicado: (2014)

Erratum to miR-499a-5p promotes 5-FU resistance and the cell proliferation and migration through activating PI3K/Akt signaling by targeting PTEN in pancreatic cancer
Publicado: (2022)

Discovery of BPR1K871, a quinazoline based, multi-kinase inhibitor for the treatment of AML and solid tumors: Rational design, synthesis, in vitro and in vivo evaluation
por: Hsu, Yung Chang, et al.
Publicado: (2016)

5-FU Metabolism in Cancer and Orally-Administrable 5-FU Drugs
por: Miura, Koh, et al.
Publicado: (2010)

Erratum to “Natural cardenolides suppress coronaviral replication by downregulating JAK1 via a Na(+)/K(+)-ATPase independent proteolysis” [Biochem. Pharmacol. 180 (2020) 114122]
por: Yang, Cheng-Wei, et al.
Publicado: (2020)

BPR1J-097, a novel FLT3 kinase inhibitor, exerts potent inhibitory activity against AML
por: Lin, W-H, et al.
Publicado: (2012)

Mechanism of acquired 5FU resistance and strategy for overcoming 5FU resistance focusing on 5FU metabolism in colon cancer cell lines
por: Suetsugu, Tomonari, et al.
Publicado: (2021)

EU Regulation of Nanobiocides: Challenges in Implementing the Biocidal Product Regulation (BPR)
por: Brinch, Anna, et al.
Publicado: (2016)

Erratum, Vol. 5: Issue 1
Publicado: (2008)

Erratum, Vol. 5: Issue 1
Publicado: (2008)

Erratum to: Rescue strategy for advanced liver malignancy with retrohepatic inferior vena cava thrombi: experience to promote surgical oncological benefit
por: Ho, Meng-Hsing, et al.
Publicado: (2017)

An Accurate Method for the Qualitative Detection and Quantification of Mycobacterial Promoter Activity: The Open Microbiology Journal, 2013, 7, 1-5 1–5
Publicado: (2013)

The role of GLI1 for 5-Fu resistance in colorectal cancer
por: Zhang, Lining, et al.
Publicado: (2017)

Aspirin suppresses chemoresistance and enhances antitumor activity of 5-Fu in 5-Fu-resistant colorectal cancer by abolishing 5-Fu-induced NF-κB activation
por: Fu, Jinbo, et al.
Publicado: (2019)

Erratum for Fu et al., Ubiquitin-Like Proteasome System Represents a Eukaryotic-Like Pathway for Targeted Proteolysis in Archaea
por: Fu, Xian, et al.
Publicado: (2016)

No effect of dose, hepatic function, or nutritional status on 5-FU clearance following continuous (5-day), 5-FU infusion.
por: Fleming, R. A., et al.
Publicado: (1992)

Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery
por: De Angelis, Paula M, et al.
Publicado: (2006)

5-FU toxicity and nutritional deficiencies.
por: Stenram, U.
Publicado: (1993)

Fluorouracil (5-FU)-induced Cardiomyopathy
por: Thalambedu, Nishanth, et al.
Publicado: (2019)

Essential Roles of mTOR/Akt Pathway in Aurora-A Cell Transformation
por: Taga, Makoto, et al.
Publicado: (2009)

Inhibition of CDK1 Reverses the Resistance of 5-Fu in Colorectal Cancer
por: Zhu, Yiping, et al.
Publicado: (2020)

Association of 5-FU Therapeutic Drug Monitoring to DPD Phenotype Assessment May Reduce 5-FU Under-Exposure
por: Dolat, Marine, et al.
Publicado: (2020)

Erratum to: ACP, volume 33, issues 1, 3–4 and 5–6, 2010
por: The Editor
Publicado: (2011)

Erratum: miR-194-5p/BCLAF1 deregulation in AML tumorigenesis
por: Dell'Aversana, C, et al.
Publicado: (2017)

Erratum to: BAP1 promotes viability and migration of ECA109 cells through KLF5/CyclinD1/FGF‐BP1
Publicado: (2021)

Eukaryotic translation initiation factor 3 subunit G (EIF3G) resensitized HCT116/5-Fu to 5-fluorouracil (5-Fu) via inhibition of MRP and MDR1
por: Yang, Chenggang, et al.
Publicado: (2018)

EPEN-30. 5FU with Radiation Followed by Maintenance of 5FU and ATRA Significantly Improves Survival of 1q+/6q- PFA Ependymoma Xenograft Models
por: Grimaldo, Enrique, et al.
Publicado: (2022)

Erratum to: ACP, volume 33, issues 1, 2, 3–4 and 5–6, 2010
por: The Editor-in-Chief
Publicado: (2011)

Erratum to: Using auriculotherapy for osteoarthritic knee among elders: a double-blinded randomised feasibility study
por: Suen, Lorna K. P., et al.
Publicado: (2016)

Erratum to “Qing-Kai-Ling Injection Acts Better Than Shen-Fu Injection in Enhancing the Antitumor Effect of Gefitinib in Resistant Non-Small Cell Lung Cancer Models”
por: Yu, Ya-Ya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_03tted3me6p0ljsu7mqa3tb9op